|
US6592877B1
(en)
|
1995-09-01 |
2003-07-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
US6458366B1
(en)
|
1995-09-01 |
2002-10-01 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
|
US6290969B1
(en)
*
|
1995-09-01 |
2001-09-18 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
PL202844B1
(pl)
|
1998-04-07 |
2009-07-31 |
Corixa Corp |
Immunogeniczny polipeptyd, polinukleotyd, polipeptyd, kompozycja farmaceutyczna, wektor ekspresji, kompozycja szczepionki, polipeptyd do stosowania w leczeniu lub zapobieganiu infekcjom Mycobacterium tuberculosis, polinukleotyd do stosowania w leczeniu lub zapobieganiu infekcjom Mycobacterium tuberculosis i sposób wytwarzania polipeptydu
|
|
DK1144447T3
(da)
*
|
1998-11-04 |
2010-02-08 |
Isis Innovation |
Dianostisk tuberkulosetest
|
|
US6432916B1
(en)
|
1998-12-08 |
2002-08-13 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US6565856B1
(en)
|
1998-12-08 |
2003-05-20 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US20020061848A1
(en)
|
2000-07-20 |
2002-05-23 |
Ajay Bhatia |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US6448234B1
(en)
|
1998-12-08 |
2002-09-10 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US6555115B1
(en)
|
1998-12-08 |
2003-04-29 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US6447779B1
(en)
|
1998-12-08 |
2002-09-10 |
Corixa Corporation |
Compounds for the diagnosis of Chlamydial infection
|
|
US7083796B2
(en)
*
|
2000-06-20 |
2006-08-01 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
|
US20030027774A1
(en)
*
|
1999-03-18 |
2003-02-06 |
Ronald C. Hendrickson |
Tuberculosis antigens and methods of use therefor
|
|
US8143386B2
(en)
*
|
1999-04-07 |
2012-03-27 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
|
AU779846B2
(en)
*
|
1999-10-07 |
2005-02-17 |
Corixa Corporation |
Methods of using a mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of heterologous proteins
|
|
US7009042B1
(en)
|
1999-10-07 |
2006-03-07 |
Corixa Corporation |
Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
|
|
EP1229931A4
(en)
|
1999-10-07 |
2003-05-28 |
Corixa Corp |
FUSION PROTEINS FROM MYCOBACTERIUM TUBERCULOSIS
|
|
US6316205B1
(en)
|
2000-01-28 |
2001-11-13 |
Genelabs Diagnostics Pte Ltd. |
Assay devices and methods of analyte detection
|
|
AU2001241738A1
(en)
*
|
2000-02-25 |
2001-09-03 |
Corixa Corporation |
Compounds and methods for diagnosis and immunotherapy of tuberculosis
|
|
GB0006692D0
(en)
*
|
2000-03-20 |
2000-05-10 |
Glaxo Group Ltd |
Epitopes
|
|
US6919187B2
(en)
|
2000-04-21 |
2005-07-19 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
WO2001081379A2
(en)
|
2000-04-21 |
2001-11-01 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
US6841159B2
(en)
|
2002-01-30 |
2005-01-11 |
The United States Of America As Represented By The Secretary Of The Navy |
Rapid lateral flow assay for determining exposure to Mycobacterium tuberculosis and other mycobacteria
|
|
US7026465B2
(en)
*
|
2002-02-15 |
2006-04-11 |
Corixa Corporation |
Fusion proteins of Mycobacterium tuberculosis
|
|
GB0321615D0
(en)
|
2003-09-15 |
2003-10-15 |
Glaxo Group Ltd |
Improvements in vaccination
|
|
WO2005061534A2
(en)
*
|
2003-12-23 |
2005-07-07 |
Statens Serum Institut |
Improved tuberculosis vaccines
|
|
US20120027841A1
(en)
|
2004-01-07 |
2012-02-02 |
Biomedical Research Models, Inc. |
Novel mucosal vaccination approach for herpes simplex virus type-2
|
|
WO2006036834A2
(en)
|
2004-09-24 |
2006-04-06 |
Amgen Inc. |
MODIFIED Fc MOLECULES
|
|
US8475735B2
(en)
|
2004-11-01 |
2013-07-02 |
Uma Mahesh Babu |
Disposable immunodiagnostic test system
|
|
CN102220357B
(zh)
|
2004-11-16 |
2013-12-25 |
克鲁塞尔荷兰公司 |
包含重组病毒载体的多价疫苗
|
|
CN100368437C
(zh)
*
|
2005-01-28 |
2008-02-13 |
中国农业科学院哈尔滨兽医研究所 |
一种诊断牛结核病的重组抗原蛋白及其制备方法
|
|
DK2457926T3
(da)
|
2005-04-29 |
2015-01-05 |
Glaxosmithkline Biolog Sa |
Ny fremgangsmåde til forebyggelse eller behandling af M. tuberkulose-infektion
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
CN100999550B
(zh)
*
|
2006-01-10 |
2010-10-06 |
中国人民解放军第三○九医院 |
结核分枝杆菌融合蛋白及其应用
|
|
CN101311189B
(zh)
*
|
2006-06-06 |
2010-09-08 |
中国人民解放军第二军医大学 |
激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途
|
|
CN101298471B
(zh)
*
|
2006-06-06 |
2011-01-19 |
中国人民解放军第二军医大学 |
激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途
|
|
CN101311190B
(zh)
*
|
2006-06-06 |
2011-08-03 |
中国人民解放军第二军医大学 |
激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途
|
|
CN100415771C
(zh)
*
|
2006-06-06 |
2008-09-03 |
中国人民解放军第二军医大学 |
激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途
|
|
EP2040745B1
(en)
*
|
2006-06-28 |
2012-12-05 |
Statens Serum Institut |
Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails
|
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
PL2068918T5
(pl)
|
2006-09-26 |
2024-12-02 |
Access To Advanced Health Institute |
Kompozycja szczepionki zawierająca syntetyczny adiuwant
|
|
EA015817B1
(ru)
|
2006-10-12 |
2011-12-30 |
Глаксосмитклайн Байолоджикалс С.А. |
Иммуногенная композиция, содержащая адъювант в виде эмульсии "масло в воде"
|
|
EP2433648A3
(en)
|
2006-10-12 |
2012-04-04 |
GlaxoSmithKline Biologicals S.A. |
Vaccine comprising an oil in water emulsion adjuvant
|
|
US9717788B2
(en)
|
2007-03-02 |
2017-08-01 |
Glaxosmithkline Biologicals Sa |
Method of inducing an immune response against HIV employing HIV immunogens, adenoviral vectors encoding said immunogens, and adjuvant
|
|
PL2137210T3
(pl)
|
2007-03-02 |
2017-06-30 |
Glaxosmithkline Biologicals Sa |
Nowy sposób i kompozycje
|
|
BRPI0809926B8
(pt)
|
2007-04-04 |
2021-05-25 |
Infectious Disease Res Inst |
composição que compreende antígenos de mycobacterium tuberculosis, polipeptídeo de fusão isolado, polinucleotídeo isolado que codifica o dito polipeptídeo e uso da dita composição para estimular uma resposta imune protetora
|
|
KR20100098602A
(ko)
*
|
2007-10-13 |
2010-09-08 |
코넬 유니버시티 |
마이코박테리움 아비움 아종 파라투베르쿨로시스에 대한 면역 응답을 유발하기 위한 조성물
|
|
KR101378240B1
(ko)
|
2008-02-22 |
2014-03-28 |
포항공과대학교 산학협력단 |
결핵 예방용 조성물
|
|
AU2009273130B2
(en)
*
|
2008-07-25 |
2014-10-16 |
Glaxo Group Limited |
Novel compositions and methods
|
|
CA2731549C
(en)
|
2008-07-25 |
2018-07-17 |
Glaxo Group Limited |
Compositions and methods for treating tuberculosis
|
|
AU2009273132B2
(en)
|
2008-07-25 |
2015-09-03 |
Glaxo Group Limited |
The tuberculosis Rv2386c protein, compositions and uses thereof
|
|
GB0815872D0
(en)
|
2008-09-01 |
2008-10-08 |
Pasteur Institut |
Novel method and compositions
|
|
AU2010222942B2
(en)
|
2009-03-10 |
2013-01-10 |
Baylor Research Institute |
Anti-CD40 antibodies and uses thereof
|
|
DK2406289T3
(en)
*
|
2009-03-10 |
2017-05-01 |
Baylor Res Inst |
ANTIGEN PRESENTING CELL TARGETED ANTIVIRUS VACCINES
|
|
CN102770457A
(zh)
*
|
2009-03-10 |
2012-11-07 |
贝勒研究院 |
靶向抗原呈递细胞的疫苗
|
|
CA2764374C
(en)
|
2009-06-05 |
2019-11-19 |
Infectious Disease Research Institute |
Synthetic glucopyranosyl lipid adjuvants
|
|
BR112012018669A2
(pt)
|
2010-01-27 |
2017-09-05 |
Glaxosmithkline Biologicals Sa |
Proteína rv3616c modificada, uso de uma proteína rv3616c modificada, polinucleotídeo, uso de um polinucleotídeo, composição farmacêutica, composição imunogênica, proteína de fusão, e, polipeptídeo.
|
|
CN106822883A
(zh)
|
2010-12-14 |
2017-06-13 |
葛兰素史密丝克莱恩生物有限公司 |
分枝杆菌抗原组合物
|
|
GB201022007D0
(en)
|
2010-12-24 |
2011-02-02 |
Imp Innovations Ltd |
DNA-sensor
|
|
CN102154324B
(zh)
*
|
2010-12-29 |
2012-11-28 |
兰州大学 |
结核分枝杆菌融合蛋白Mtb10.4-Hsp16.3的构建、表达和纯化方法及其应用
|
|
CA2831294A1
(en)
|
2011-03-25 |
2012-10-04 |
Baylor Research Institute |
Compositions and methods to immunize against hepatitis c virus
|
|
EA027236B1
(ru)
|
2011-04-08 |
2017-07-31 |
Иммьюн Дизайн Корп. |
Иммуногенные композиции и способы применения таких композиций для индукции гуморального и клеточного иммунного ответа
|
|
US20120288515A1
(en)
|
2011-04-27 |
2012-11-15 |
Immune Design Corp. |
Synthetic long peptide (slp)-based vaccines
|
|
CN102305855A
(zh)
*
|
2011-05-19 |
2012-01-04 |
中山大学 |
体外检测结核分枝杆菌感染的试剂和方法
|
|
WO2013063059A1
(en)
*
|
2011-10-24 |
2013-05-02 |
University Of Central Florida Research Foundation, Inc. |
Plastid-expressed mycobacterium tuberculosis vaccine antigens esat-6 and mtb72f fused to cholera toxin b subunit
|
|
ES2729967T3
(es)
|
2012-02-07 |
2019-11-07 |
Infectious Disease Res Inst |
Formulaciones de adyuvante mejoradas que comprenden agonistas de TLR4 y métodos para usar las mismas
|
|
MX347154B
(es)
|
2012-02-24 |
2017-02-21 |
Centro De Investigación Científica Y De Educación Superior De Ensenada Baja California (Cicese) |
Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.
|
|
HRP20181102T1
(hr)
|
2012-05-16 |
2018-09-07 |
Immune Design Corp |
Cjepiva za hsv-2
|
|
CN102757971B
(zh)
*
|
2012-08-07 |
2013-09-11 |
中国人民解放军第三O九医院 |
一种结核分枝杆菌重组蛋白质及其制备方法
|
|
JP6470179B2
(ja)
*
|
2012-10-23 |
2019-02-13 |
スタテンス セールム インスティトゥート |
結核菌（ｍ．ｔｕｂｅｒｃｕｌｏｓｉｓ）ワクチン
|
|
WO2014107731A1
(en)
|
2013-01-07 |
2014-07-10 |
Biomedical Research Models, Inc. |
Therapeutic vaccines for treating herpes simplex virus type 2 infections
|
|
KR20150127587A
(ko)
*
|
2013-03-15 |
2015-11-17 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
결핵의 예방 또는 치료를 위한 합성 면역원
|
|
MX370573B
(es)
|
2013-04-18 |
2019-12-17 |
Immune Design Corp |
Monoterapia con glucopiranosil lipido a para usarse en el tratamiento del cancer.
|
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
|
IL310015B2
(en)
|
2013-12-31 |
2026-02-01 |
Access To Advanced Health Inst |
Single vial formulation
|
|
CN120939216A
(zh)
|
2014-01-13 |
2025-11-14 |
贝勒研究院 |
抗hpv和hpv相关的疾病的新疫苗
|
|
WO2017151818A2
(en)
*
|
2016-03-02 |
2017-09-08 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides and methods of use thereof
|
|
WO2017176076A1
(en)
|
2016-04-06 |
2017-10-12 |
Ewha University - Industry Collaboration Foundation |
A peptide with ability to penetrate cell membrane
|
|
WO2017200957A1
(en)
|
2016-05-16 |
2017-11-23 |
Infectious Disease Research Institute |
Pegylated liposomes and methods of use
|
|
MX2018014086A
(es)
|
2016-05-16 |
2019-09-18 |
Infectious Disease Res Inst |
Formulacion que contiene agonista tlr y metodos de uso.
|
|
KR20250008135A
(ko)
|
2016-06-01 |
2025-01-14 |
액세스 투 어드밴스드 헬스 인스티튜트 |
사이징제를 함유하는 나노명반 입자
|
|
MX2019015076A
(es)
|
2017-06-15 |
2020-08-03 |
Infectious Disease Res Inst |
Portadores lípidos nanoestructurados y emulsiones estables y usos de los mismos.
|
|
WO2019051149A1
(en)
|
2017-09-08 |
2019-03-14 |
Infectious Disease Research Institute |
LIPOSOMAL FORMULATIONS COMPRISING SAPONIN AND METHODS OF USE
|
|
US10610585B2
(en)
|
2017-09-26 |
2020-04-07 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and compositions for treating and preventing HIV
|
|
CN109825497A
(zh)
*
|
2019-01-25 |
2019-05-31 |
石河子大学 |
一种新型结核杆菌融合菌株的制备方法及其应用
|
|
CA3141577A1
(en)
|
2019-05-25 |
2020-12-03 |
Infectious Disease Research Institute |
Composition and method for spray drying an adjuvant vaccine emulsion
|
|
CA3266697A1
(en)
|
2022-09-09 |
2024-03-14 |
Access To Advanced Health Institute |
COMPOSITION OF AN IMMUNOGENEOUS VACCINE CONTAINING A SAPONIN
|
|
CN118652311B
(zh)
*
|
2024-07-17 |
2025-02-25 |
扬州大学 |
结核分枝杆菌复合体ⅶ型分泌系统效应蛋白cfp10保守功能性b细胞表位及其应用
|